Published in Ann Rheum Dis on August 01, 1990
The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med (1962) 23.03
Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med (1973) 14.88
Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med (1988) 7.12
Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens (1974) 5.08
Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med (1989) 3.68
Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10
Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis (1987) 1.63
Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. J Clin Invest (1986) 1.41
Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum (1988) 1.35
Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism. Infect Immun (1979) 1.27
Yersinia in intestinal biopsy specimens from patients with seronegative spondyloarthropathy: correlation with specific serum IgA antibodies. J Infect Dis (1989) 1.25
Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21
Reactive arthritis. Clin Rheum Dis (1985) 1.18
Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol (1988) 1.16
Polymorphonuclear cell function in rheumatoid arthritis and in Felty's syndrome. Ann Rheum Dis (1981) 1.15
Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27. Ann Rheum Dis (1984) 1.05
Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human lymphotoxin. Promotion of adherence, inhibition of chemotactic migration and superoxide anion release from adherent cells. Clin Exp Immunol (1988) 1.04
Stimulation of human neutrophil chemiluminescence by soluble immune complexes and antibodies to neutrophils. J Lab Clin Med (1981) 1.00
Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis. Ann Rheum Dis (1984) 0.98
Defective polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis associated with a serum inhibitor. Ann Rheum Dis (1980) 0.97
Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteoarthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase. Ann Rheum Dis (1986) 0.96
The amplified chemiluminescence test to characterize antirheumatic drugs as oxygen radical scavengers. Biochem Pharmacol (1987) 0.94
Reactive arthritis associated with Shigella sonnei infection. Arthritis Rheum (1988) 0.92
Migration of blood and synovial fluid neutrophils obtained from patients with rheumatoid arthritis. Clin Exp Immunol (1980) 0.90
Chemiluminescence of polymorphonuclear leukocytes from rheumatoid joints. J Rheumatol (1983) 0.89
Chemotactic activity of lymphotoxin and tumour necrosis factor alpha for human neutrophils. Immunology (1989) 0.88
Neutrophil activation by immune complexes and the role of rheumatoid factor. Ann Rheum Dis (1984) 0.87
Leukocyte migration agarose test for the assessment of human neutrophil chemotaxis. II. Variables in the attraction assay. Scand J Immunol (1977) 0.86
Changes in normal polymorphonuclear leucocyte motility after ingestion of IgG aggregates. Ann Rheum Dis (1984) 0.85
Aberrant phagocyte function in Shwachman syndrome. Clin Exp Immunol (1987) 0.85
The generation of superoxide anions by polymorphonuclear leucocytes from patients with ankylosing spondylitis in response to the stimulant f-met-leu-phe. Clin Exp Rheumatol (1986) 0.85
Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations. Ann Rheum Dis (1988) 0.85
Inhibition by nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formyl-methionyl-leucyl-phenylalanine. Biochem Pharmacol (1987) 0.84
Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease. Ann Rheum Dis (1987) 0.84
Blood polymorphonuclear behavior in patients with ankylosing spondylitis. Clin Exp Rheumatol (1989) 0.83
Characterization of circulating Yersinia-specific immune complexes in patients with yersiniosis. Clin Immunol Immunopathol (1987) 0.83
Neutrophil responsiveness to chemoattractant tripeptide in rheumatoid arthritis. Proc Soc Exp Biol Med (1987) 0.79
Polymorphonuclear leucocyte motility in men with ankylosing spondylitis. Ann Rheum Dis (1989) 0.79
Experience with a skin chamber technique for leucocyte migration studies. Immunol Lett (1985) 0.76
Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med (1988) 4.67
Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum (1991) 2.10
Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg (2001) 1.68
Leukocyte migration agarose test for the assessment of human neutrophil chemotaxis. I. Effects of environmental factors on neutrophil migration under agarose. Scand J Immunol (1977) 1.50
Transhepatic neutrophil and monocyte activation during clinical liver transplantation. Transplantation (2000) 1.44
Granulocyte colony-stimulating factor therapy and systemic inflammation in critically ill patients. Inflamm Res (2005) 1.43
Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum (1988) 1.35
Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21
Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med (2001) 1.18
Reactive arthritis. Clin Rheum Dis (1985) 1.18
Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera. Arthritis Rheum (1982) 1.12
Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics (2001) 1.08
Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis (2007) 1.07
Oral infections and systemic disease--an emerging problem in medicine. Clin Microbiol Infect (2007) 1.07
Enhanced neutrophil migration in vivo HLA B27 positive subjects. Ann Rheum Dis (1984) 1.06
Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann N Y Acad Sci (1994) 1.06
Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br J Surg (2005) 1.05
Chronic osteomyelitislike disease with negative bacterial cultures. Am J Dis Child (1988) 1.02
Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. J Periodontol (1993) 1.01
Capnocytophaga canimorsus septicemia: fifth report of a cat-associated infection and five other cases. Eur J Clin Microbiol Infect Dis (1995) 0.99
Tryptophan catabolites in mesenteric lymph may contribute to pancreatitis-associated organ failure. Br J Surg (2008) 0.98
Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int (1998) 0.98
Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol (1999) 0.96
Use of leucocyte migration under agarose to study spontaneous and directed locomotion of leucocytes. Immunology (1978) 0.96
Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol (2001) 0.95
The regulatory role of doxycycline/tetracycline in collagenolytic activity and tissue destruction in joint diseases: comment on the article by Yu et al. Arthritis Rheum (1993) 0.95
Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci (Lond) (1999) 0.93
Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res (1997) 0.93
Reactive arthritis associated with Shigella sonnei infection. Arthritis Rheum (1988) 0.92
Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. J Infect Dis (2000) 0.90
Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate). Calcif Tissue Int (1997) 0.89
Are antibiotics of any use in reactive arthritis? APMIS (1993) 0.89
Polymorphism at position +896 of the toll-like receptor 4 gene interferes with rapid response to treatment in rheumatoid arthritis. Ann Rheum Dis (2006) 0.89
Patient-reported complications associated with Campylobacter jejuni infection. Epidemiol Infect (2009) 0.88
Plasma anti-inflammatory cytokines and monocyte human leucocyte antigen-DR expression in patients with acute pancreatitis. Scand J Gastroenterol (2004) 0.88
Standardization of a flow cytometric assay for phagocyte respiratory burst activity. Scand J Immunol (1996) 0.88
Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis. Med Biol (1984) 0.88
Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. Eur J Clin Microbiol Infect Dis (2004) 0.87
Neutrophil function and HLA-B27. Br J Rheumatol (1983) 0.86
A novel modification of a flow cytometric assay of phosphorylated STAT1 in whole blood monocytes for immunomonitoring of patients on IFN alpha regimen. Scand J Immunol (2007) 0.86
Leukocyte migration agarose test for the assessment of human neutrophil chemotaxis. II. Variables in the attraction assay. Scand J Immunol (1977) 0.86
Defective neutrophil migration in monosomy-7. Blood (1981) 0.84
Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease. Ann Rheum Dis (1987) 0.84
Leucocyte motility in the newborn: determination of spontaneous movement is essential in the in vitro assessment of neutrophil chemotaxis. Clin Exp Immunol (1980) 0.84
Constant defect in neutrophil locomotion but with age decreasing susceptibility to infection in Shwachman syndrome. Clin Exp Immunol (1984) 0.84
Functions of polymorphonuclear leukocytes in early rheumatoid arthritis. Inflammation (1993) 0.84
Impaired neutrophil chemotaxis in Pelger-Huët anomaly. Clin Exp Immunol (1979) 0.84
Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study. Ann Rheum Dis (2002) 0.84
Systemic inflammation and innate immune response in patients with previous anterior uveitis. Br J Ophthalmol (2002) 0.83
Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug. Clin Exp Rheumatol (2005) 0.83
Production of TNF by monocytes of patients with early rheumatoid arthritis is increased. Scand J Rheumatol (1995) 0.83
Potentiative effects of neutral proteinases in an inflamed lung: relationship of neutrophil procollagenase (proMMP-8) to plasmin, cathepsin G and tryptase in bronchiectasis in vivo. Eur Respir J (1997) 0.83
Phagocyte function in familial hypercholesterolaemia: peripheral blood monocytes exposed to lipopolysaccharide show increased tumour necrosis factor production. Scand J Immunol (1990) 0.83
Luminol-enhanced chemiluminescence of whole blood. Statistical analysis, and comparison of the responses of different subjects. APMIS (1989) 0.83
Infectious background of patients with a history of acute anterior uveitis. Ann Rheum Dis (2002) 0.83
Gut and spondyloarthropathies. Rheum Dis Clin North Am (1992) 0.82
Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland. Clin Microbiol Infect (2010) 0.82
The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation. Transplant Proc (2005) 0.82
Substrate specificity and activation mechanisms of collagenase from human rheumatoid synovium. Matrix (1991) 0.81
Neutrophils of healthy subjects with a history of reactive arthritis show enhanced responsiveness, as defined by CD11b expression in adherent and non-adherent whole blood cultures. Rheumatology (Oxford) (2007) 0.80
Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab. Ann Rheum Dis (2005) 0.80
Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence. Ann Rheum Dis (1991) 0.80
Antibody- and complement-dependent cell injury assayed by 51Cr release from human peripheral blood mononuclear cells pretreated with lipopolysaccharide. Infect Immun (1987) 0.80
Cord blood monocytes, neutrophils and lymphocytes from preterm and full-term neonates show multiple aberrations in signalling profiles measured using phospho-specific whole-blood flow cytometry. Scand J Immunol (2013) 0.80
Increased collagenase activity in human rheumatoid meniscus. Scand J Rheumatol (1986) 0.80
Peripheral blood monocytes from patients with reactive arthritis show normal production of tumour necrosis factor-alpha. Clin Exp Immunol (1991) 0.80
Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation. Clin Exp Immunol (1980) 0.80
Circulating soluble interleukin-2 receptor level predicts remission in very early reactive arthritis. Scand J Rheumatol (2005) 0.80
The role of unfinished root canal treatment in odontogenic maxillofacial infections requiring hospital care. Clin Oral Investig (2012) 0.79
Asbestos fibers induce release of collagenase by human polymorphonuclear leukocytes. Immunol Lett (1990) 0.79
Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency. Clin Sci (Lond) (1999) 0.79
Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma. Allergy (2010) 0.79
Time course of beta 2-integrin CD11b/CD18 (Mac-1, alpha M beta 2) upregulation on neutrophils and monocytes after coronary artery bypass grafting. CD11b upregulation after CABG surgery. Scand J Thorac Cardiovasc Surg (1996) 0.79
Inhaled recombinant interferon gamma in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes. Int J Radiat Oncol Biol Phys (1995) 0.79
Diagnosis of falciparum malaria delayed by long incubation period and misleading presenting symptoms: life-saving role of manual leucocyte differential count. Scand J Infect Dis (1989) 0.79
T-lymphocytes in human spleen. Lancet (1973) 0.79
Peripheral blood phagocyte CD14 and CD11b expression on admission to hospital in relation to mortality among patients with community-acquired infection. Inflamm Res (2005) 0.79
Endotoxins induce and interferon alpha suppresses vascular endothelial growth factor (VEGF) production in human peripheral blood mononuclear cells. FASEB J (2001) 0.78
Tetracyclines in treatment of rheumatoid arthritis. Lancet (1995) 0.78
Evaluation of red blood cell lysing solutions in the study of neutrophil oxidative burst by the DCFH assay. Cytometry (2001) 0.78
Circulating immune complexes in Yersinia infection. J Rheumatol (1984) 0.78
Enteropathic arthritis, Whipple's disease, juvenile spondyloarthropathy, and uveitis. Curr Opin Rheumatol (1994) 0.78
Exaggerated inflammatory responsiveness plays a part in the pathogenesis of HLA-B27 linked diseases--hypothesis. Ann Clin Res (1984) 0.77
Cathepsin G and elastase in synovial fluid and peripheral blood in reactive and rheumatoid arthritis. Clin Rheumatol (1996) 0.77
Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma. Br J Cancer (2002) 0.77
Activated protein C and inflammation in human myocardium after heart surgery. Am J Hematol (2001) 0.77
Reactive arthritis. Consider combination treatment. BMJ (1994) 0.77
Neutrophil chemotaxis under agarose: a statistical analysis and comparison of the chemotactic response of cells from different donors. J Immunol Methods (1981) 0.77
Etretinate therapy and neutrophil function in a patient with reactive arthritis triggered by Salmonella infantis. Clin Exp Rheumatol (1988) 0.77
Signalling profiles of circulating leucocytes in patients recovered from reactive arthritis. Scand J Rheumatol (2012) 0.76
Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytes. J Immunother Emphasis Tumor Immunol (1994) 0.76
Complement activation and HLA-B27. Ann Rheum Dis (1988) 0.76
Early dexamethasone decreases expression of activation markers on neutrophils and monocytes in preterm infants. Acta Paediatr (2002) 0.76
Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I. Acta Pathol Microbiol Immunol Scand C (1986) 0.76
Yersinia arthritis, immune functions and histocompatibility antigens. Acta Pathol Microbiol Immunol Scand C (1986) 0.76
Matrix metalloproteinases-1, -3 and -8 and myeloperoxidase in saliva of patients with human immunodeficiency virus infection. Oral Dis (1996) 0.76
Gold(I) compounds and human neutrophil collagenase. J Rheumatol (1989) 0.75
Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures. Ann Rheum Dis (2005) 0.75